NCT03745885View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Supaglutide in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 4, 2018

Primary Completion Date

June 10, 2019

Study Completion Date

December 13, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Supaglutide injection

Administered SC in the Supaglutide arms.

DRUG

Placebo

Administered SC in the placebo arms and to maintain the blind in the Supaglutide injection arms.

Trial Locations (1)

210000

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing

All Listed Sponsors
collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

lead

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

OTHER

NCT03745885 - A Study of the Efficacy and Safety of Supaglutide in Healthy Participants | Biotech Hunter | Biotech Hunter